An update on heart transplantation in human immunodeficiency virus-infected patients

American Journal of Transplantation

Volumn 16, Issue 1, 2016, Pages 21-28

  Aguero F ^a   Castel, M A ^a   Cocchi, S ^b   Moreno, A ^a   Mestres, C A ^a   Cervera, C ^a   Perez Villa F ^a   Tuset, M ^a   Cartana R ^a   Manzardo, C ^a   Guaraldi, G ^b   Gatell, J M ^a   Miro J M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTACID AGENT; ATAZANAVIR; COBICISTAT; DARUNAVIR; DOLUTEGRAVIR; EMTRICITABINE; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; LOPINAVIR; MARAVIROC; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RALTEGRAVIR; SIMVASTATIN; TENOFOVIR;

CARDIAC GRAFT REJECTION; CARDIOVASCULAR DISEASE; EPIDEMIOLOGICAL DATA; ETHICS; HEALTH CARE ACCESS; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; ORGAN DONOR; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPLICATION; HEART FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PROGNOSIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HEART FAILURE; HEART TRANSPLANTATION; HIV INFECTIONS; HUMANS; PROGNOSIS;

EID: 84956962032     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13496     Document Type: Review

References (40)

1. Kendall CE, Wong J, Taljaard M, et al., A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario. BMC Public Health 2014; 14: 161.
2. Uriel N, Nahumi N, Colombo PC, et al., Advanced heart failure in patients infected with human immunodeficiency virus: Is there equal access to care ? J Heart Lung Transplant 2014; 33: 924-930.
3. Uriel N, Jorde UP, Cotarlan V, et al., Heart transplantation in human immunodeficiency virus-positive patients. J Heart Lung Transplant 2009; 28: 667-669.
4. Pelletier S, Norman SP, Christensen L, Stock PG, Port FK, Merion RM., Review of transplantation in HIV patients during the HAART era. Clin Transpl 2004; 63-82
5. Castel MA, Pérez-Villa F, Mirõ JM., Heart transplantation in HIV-infected patients: More cases in Europe. J Heart Lung Transplant 2011; 30: 1418.
6. Cerrato E, D'Ascenzo F, Biondi-Zoccai G, et al., Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: A meta-analysis in the highly active antiretroviral therapy era. Eur Heart J 2013; 34: 1432-1436.
7. Locke JE, Mehta S, Reed RD, et al., A national study of outcomes among HIV-infected kidney transplant recipients. J Am Soc Nephrol 2015; 26: 2222-2229.
8. Miro JM, Montejo M, Castells L, et al., Outcome of HCV/HIV-coinfected liver transplant recipients: A prospective and multicenter cohort study. Am J Transplant 2012; 12: 1866-1876.
9. Terrault NA, Roland ME, Schiano T, et al., Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012; 18: 716-726.
10. Coffin CS, Stock PG, Dove LM, et al., Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. Am J Transplant 2010; 10: 1268-1275.
11. Sims DB, Uriel N, González-Costello J, et al., Human immunodeficiency virus infection and left ventricular assist devices: A case series. J Heart Lung Transplant 2011; 30: 1060-1064.
12. Krishan K, Pinney S, Anyanwu AC., Successful left ventricular assist device bridge to transplantation in a patient with end-stage heart failure and human immunodeficiency virus. Artif Organs 2012; 36: 759.
13. Castel MA., Heart transplantation in an HIV-1-infected patient with ischemic cardiomyopathy and severe pulmonary hypertension [in Spanish]. Rev Esp Cardiol 2011; 64: 1066-1067.
14. Calabrese LH, Albrecht M, Young J, et al., Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med 2003; 348: 2323-2328.
15. Bisleri G, Morgan JA, Deng MC, Mancini DM, Oz MC,. Should HIV-positive recipients undergo heart transplantation ? J Thorac Cardiovasc Surg 2003; 126: 1639-1640.
16. Ahn J, Cohen S,. Reply: Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transplant 2009; 15: 562.
17. Anthuber M, Kemkes B, Heiss M, Schuetz A, Kugler C., HIV infection after heart transplantation: A case report. J Heart Lung Transpl 1991; 10: 611-613.
18. Boignard A, Blanc M, Chavanon O., High-urgency priority heart transplantation in HIV-positive patients on life support: Breaking barriers ? J Heart Lung Transplant 2011; 30: 967-968.
19. Calabrese F, Angelini A, Cecchetto A, Valente M, Livi U, Thiene G., HIV infection in the first heart transplantation in Italy: Fatal outcome. Case report. APMIS 1998; 106: 470-474.
20. Dummer JS, Erb S, Breinig MK, et al., Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989; 47: 134-140.
21. Durante-Mangoni E., Management of immunosuppression and antiviral treatment before and after heart transplant for HIV-associated dilated cardiomyopathy. Int J Immunopathol Pharm 2014; 27: 74.
22. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH., Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review. Rev Infect Dis 1991; 13: 537-547.
23. Gupta S, Markham DW, Mammen PP, et al., Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant. Am J Transplant 2008; 8: 893-896.
24. Ison MG, Llata E, Conover CS, et al., Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant 2011; 11: 1218-1225.
25. Ragni M., Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med 1990; 332: 1886-1887.
26. Simmonds R., Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-732.
27. Tambini R, Fiocchi R, Gavazzeni G., Human immunodeficiency virus infection after heart transplantation: Development of cardiomyopathy after long-term survival. Int J Infect Dis 1997; 2: 40-43.
28. Tzakis A., Transplantation in HIV+ patients. Transplantation 1990; 49: 354-358.
29. Aberg JA, Zackin RA, Brobst SW, et al., A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Res Hum Retroviruses 2005; 21: 757-767.
30. Angheben A, Buonfrate D, Gobbi F, et al., Heart transplant in a patient with HIV-Chagas Disease coinfection. First case report. Trop Med Int Heal 2013; suppl 1: 130. 8th European Congress on Tropical Medicine and International Health; 2013 Sept 10-13; Copenhagen. Abstract P.1.4.9.002 (B).
31. Mancini D, Lietz K., Selection of cardiac transplantation candidates in 2010. Circulation 2010; 122: 173-183.
32. Mirõ JM, Torre-Cisnero J, Moreno A, et al., GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005) [in Spanish]. Enferm Infecc Microbiol Clin 2006; 23: 353-362.
33. Blumberg EA, Rogers CC., Human immunodeficiency virus in solid organ transplantation. Am J Transplant 2013; 13: 169-178.
34. Jahangiri B, Haddad H., Cardiac transplantation in HIV-positive patients: Are we there yet ? J Heart Lung Transplant 2007; 26: 103-107.
35. Günthard HF, Aberg JA, Eron JJ, et al., Antiretroviral treatment of adult HIV infection: 2014 Recommendations of the International Antiviral Society-USA Panel. JAMA 2014; 312: 410-425.
36. Frassetto L, Floren L, Barin B, et al., Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. Biopharm Drug Dispos 2013; 34: 442-451.
37. Back D, Gibbons S,. The University of Liverpool HIV drug interactions website. [cited 2015 Jul 20]. http://www.hiv-druginteractions.org/.
38. Tricot L, Teicher E, Peytavin G, et al., Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant 2009; 9: 1946-1952.
39. Costanzo MR, Dipchand A, Starling R, et al., The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010; 29: 914-956.
40. Miro JM, Agüero F, Duclos-Vallée J-C, Mueller NJ, Grossi P, Moreno A,. Infections in solid organ transplant HIV-infected patients. Clin Microbiol Infect 2014; 20(Suppl 7): 119-130.